23 May 2013
Keywords: liraglutide, cuts, weight, obese, non-diabetics, data, phase
Article | 26 November 2007
Data from a Phase II study comparing Danish insulin specialist Novo Nordisk's GLP-1 analog, liraglutide, with the lipase inhibitor orlistat ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.